ArticleInfectious diseases and therapy2025

A Phase II, Randomised, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of HEX17, a Novel Broad-Spectrum Antiviral Drug, in a Controlled Human Infection Model of Influenza Challenge.

Geoff Kitson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.